• 1
    Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation: United States, 2007-2009. MMWR Morb Mortal Wkly Rep 2010; 59: 12615.
  • 2
    Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 26981.
  • 3
    Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002; 4 Suppl 3: S26572.
  • 4
    Kim JM, Weisman MH. When does rheumatoid arthritis begin and why do we need to know? [review]. Arthritis Rheum 2000; 43: 47384.
  • 5
    Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003; 21: S1547.
  • 6
    Wilke WS, Sweeney TJ, Calabrese LH. Early, aggressive therapy for rheumatoid arthritis: concerns, descriptions, and estimate of outcome. Semin Arthritis Rheum 1993; 23: 2641.
  • 7
    Backhaus M, Kamradt T, Sandrock D, Loreck D, Fritz J, Wolf KJ, et al. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum 1999; 42: 123245.
  • 8
    Terslev L, Torp-Pedersen S, Savnik A, von der Recke P, Qvistgaard E, Danneskiold-Samsoe B, et al. Doppler ultrasound and magnetic resonance imaging of synovial inflammation of the hand in rheumatoid arthritis: a comparative study. Arthritis Rheum 2003; 48: 243441.
  • 9
    Szkudlarek M, Klarlund M, Narvestad E, Court-Payen M, Strandberg C, Jensen KE, et al. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther 2006; 8: R52.
  • 10
    Brown AK. Using ultrasonography to facilitate best practice in diagnosis and management of RA. Nat Rev Rheumatol 2009; 5: 698706.
  • 11
    Wakefield RJ, O'Connor PJ, Conaghan PG, McGonagle D, Hensor EM, Gibbon WW, et al. Finger tendon disease in untreated early rheumatoid arthritis: a comparison of ultrasound and magnetic resonance imaging. Arthritis Rheum 2007; 57: 115864.
  • 12
    Chen WT, Mahmood U, Weissleder R, Tung CH. Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 2005; 7: R3107.
  • 13
    Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004; 50: 245965.
  • 14
    Meier R, Krug C, Golovko D, Boddington S, Piontek G, Rudelius M, et al. Indocyanine green–enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system. Arthritis Rheum 2010; 62: 23227.
  • 15
    Fischer T, Gemeinhardt I, Wagner S, Stieglitz DV, Schnorr J, Hermann KG, et al. Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis. Acad Radiol 2006; 13: 413.
  • 16
    Fischer T, Ebert B, Voigt J, Macdonald R, Schneider U, Thomas A, et al. Detection of rheumatoid arthritis using non-specific contrast enhanced fluorescence imaging. Acad Radiol 2010; 17: 37581.
  • 17
    Hansch A, Frey O, Hilger I, Sauner D, Haas M, Schmidt D, et al. Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest Radiol 2004; 39: 62632.
  • 18
    Hansch A, Frey O, Sauner D, Hilger I, Haas M, Malich A, et al. In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum 2004; 50: 9617.
  • 19
    Simon GH, Daldrup-Link HE, Kau J, Metz S, Schlegel J, Piontek G, et al. Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe. Eur J Nucl Med Mol Imaging 2006; 33: 9981006.
  • 20
    Scheel AK, Krause A, Mesecke-von Rheinbaben I, Metzger G, Rost H, Tresp V, et al. Assessment of proximal finger joint inflammation in patients with rheumatoid arthritis, using a novel laser-based imaging technique. Arthritis Rheum 2002; 46: 117784.
  • 21
    Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 2004; 137: 60914.
  • 22
    Brancato R, Trabucchi G. Fluorescein and indocyanine green angiography in vascular chorioretinal diseases. Semin Ophthalmol 1998; 13: 18998.
  • 23
    El Desoky A, Seifalian AM, Cope M, Delpy DT, Davidson BR. Experimental study of liver dysfunction evaluated by direct indocyanine green clearance using near infrared spectroscopy. Br J Surg 1999; 86: 100511.
  • 24
    Haruna M, Kumon K, Yahagi N, Watanabe Y, Ishida Y, Kobayashi N, et al. Blood volume measurement at the bedside using ICG pulse spectrophotometry. Anesthesiology 1998; 89: 13228.
  • 25
    Gurfinkel M, Thompson AB, Ralston W, Troy TL, Moore AL, Moore TA, et al. Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study. Photochem Photobiol 2000; 72: 94102.
  • 26
    Haglund MM, Berger MS, Hochman DW. Enhanced optical imaging of human gliomas and tumor margins. Neurosurgery 1996; 38: 30817.
  • 27
    Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 2000; 97: 276772.
  • 28
    Reynolds JS, Troy TL, Mayer RH, Thompson AB, Waters DJ, Cornell KK, et al. Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem Photobiol 1999; 70: 8794.
  • 29
    Mordon S, Devoisselle JM, Soulie-Begu S, Desmettre T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res 1998; 55: 14652.
  • 30
    Meijer DK, Weert B, Vermeer GA. Pharmacokinetics of biliary excretion in man. VI. Indocyanine green. Eur J Clin Pharmacol 1988; 35: 295303.
  • 31
    Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies: core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003; 30: 13856.
  • 32
    Ostergaard M, McQueen F, Wiell C, Bird P, Boyesen P, Ejbjerg B, et al. The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA hands. J Rheumatol 2009; 36: 181624.
  • 33
    Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 1322.
  • 34
    Smith P, Hadgu A. Sensitivity and specificity for correlated observations. Stat Med 1992; 11: 15039.
  • 35
    Drake C, Levine RA. Sensitivity, specificity and other diagnostic measures with multiple sites per unit. Contemp Clin Trials 2005; 26: 2529.
  • 36
    Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. New York: John Wiley & Sons; 2003.
  • 37
    Meyer D, Zeileis A, Hornik K. vcd: Visualizing categorical data. R package version 1. 2-9; 2010.
  • 38
    Carey VJ. Ported to R by Ripley B. gee: Generalized estimation equation solver. R package version 4.13-16, 2010.
  • 39
    Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol 1993; 46: 4239.
  • 40
    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 15974.
  • 41
    Werner SG, Langer HE, Ohrndorf S, Bahner M, Schott P, Schwenke C, et al. Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology. Ann Rheum Dis 2012; 71: 50410.
  • 42
    Golovko D, Meier R, Rummeny E, Daldrup-Link H. Optical imaging of rheumatoid arthritis. Int J Clin Rheumatol 2011; 6: 6775.
  • 43
    Peterson JD, Labranche TP, Vasquez KO, Kossodo S, Melton M, Rader R, et al. Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis. Arthritis Res Ther 2010; 12: R105.
  • 44
    Berezin MY, Achilefu S. Fluorescence lifetime measurements and biological imaging. Chem Rev 2010; 110: 264184.
  • 45
    Levenson RM. Spectral imaging and pathology: seeing more. Lab Med 2004; 35: 24451.
  • 46
    Delle SA, Riente L, Bombardieri S. Limits and perspectives of ultrasound in the diagnosis and management of rheumatic diseases. Mod Rheumatol 2008; 18: 12531.